TrialCardiovascular diabetology2023

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.

Naoto Katakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.